An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Significant Ki-67 protein suppression in HR-positive, HER2-negative breast cancer was seen among patients treated with ...

People living in long-impoverished areas are more likely to have aggressive or advanced breast cancer, undergo the most ...

Medicaid expansion was associated with a slower decrease in receipt of guideline-concordant treatment, reduced delays in treatment initiation, and improved 2-year survival, according to researchers.

The FDA recently approved the combination of inavolisib, fulvestrant, and palbociclib in this patient population.

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...